Velká Británie. Medicines and Healthcare Products Regulatory Agency
Wielka Brytania. Medicines and Healthcare Products Regulatory Agency.
Great Britain. Medicines and Healthcare products Regulatory Agency
Medicines and Healthcare products Regulatory Agency Medicine regulation agency in the UK
Medicines and Healthcare products Regulatory Agency
Großbritannien Medicines and Healthcare Products Regulatory Agency
Medicines and Healthcare products Regulatory Agency (Londres, Royaume-Uni)
Grande-Bretagne. Medicines and Healthcare products Regulatory Agency
VIAF ID: 152320195 ( Corporate )
Permalink: http://viaf.org/viaf/152320195
Preferred Forms
-
- 110 1 _ ‡a Great Britain. ‡b Medicines and Healthcare products Regulatory Agency
- 110 1 _ ‡a Großbritannien ‡b Medicines and Healthcare Products Regulatory Agency
-
- 110 2 _ ‡a Medicines and Healthcare products Regulatory Agency (Londres, Royaume-Uni)
- 110 2 _ ‡a Medicines and Healthcare products Regulatory Agency ‡c Medicine regulation agency in the UK
- 110 2 _ ‡a Velká Británie ‡b Medicines and Healthcare products Regulatory Agency
-
-
4xx's: Alternate Name Forms (25)
5xx's: Related Names (12)
- 510 1 _ ‡a Great Britain. ‡b Department of Health
- 510 1 _ ‡a Great Britain. ‡b Medical Devices Agency
- 510 1 _ ‡a Great Britain. ‡b Medicines Control Agency
- 510 2 _ ‡a Great Britain ‡b Medical Devices Agency
- 510 2 _ ‡a Great Britain ‡b Medicines Control Agency
- 551 _ _ ‡a Großbritannien
- 510 1 _ ‡a Großbritannien ‡b Medical Devices Agency ‡e Vorgaenger
- 510 1 _ ‡a Großbritannien ‡b Medicines Control Agency ‡e Vorgaenger
- 510 1 _ ‡a Velká Británie. ‡b Medical Devices Agency
- 510 1 _ ‡a Velká Británie. ‡b Medicines Control Agency
- 510 2 _ ‡a Velká Británie ‡b Medical Devices Agency
- 510 2 _ ‡a Velká Británie ‡b Medicines Control Agency
Works
Title | Sources |
---|---|
Annual report and accounts | |
Current Problems in Pharmacovigilance | |
GE lightspeed ultra advantage, c2003: | |
Good pharmacovigilance practice guide | |
La légitimation des agences de réglementation des produits de santé : entre utilitarisme et déontologisme, une analyse illustrée par l'ANSM et la MHRA | |
MHRA evaluation report | |
Rules and guidance for pharmaceutical manufacturers and distributors 2017 |